Animal experiments using single organs as models of fibrosis spur therapeutic development toward promising targets, but testing of these therapies in human fibrosis yielded disappointing results and limited efficacy. Finding core pathways relevant in different organs that can become fibrotic will uncover molecules that will prove useful as therapeutic targets in many species, including humans. In 'Bench to Bedside', Scott Friedman, Wajahat Mehal and John Iredale discuss this new paradigm in fibrosis research and its potential as a new drug development approach. In 'Bedside to Bench', Alison Eddy peruses how the protein encoded by UMOD, a gene linked to variable risk for chronic kidney disease and hypertension in humans, may have a role in fibrosis and kidney disease. Uncovering the normal function of UMOD and its gene variants will shed light on the pathogenesis of chronic kidney disease and aid in the discovery of new targets for kidney fibrosis and hypertension.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The potential role of miRNAs and regulation of their expression in the development of mare endometrial fibrosis
Scientific Reports Open Access 24 September 2023
-
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction
Nature Communications Open Access 10 January 2022
-
Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway
Journal of Biomedical Science Open Access 09 May 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wynn, T.A. J. Pathol. 214, 199–210 (2008).
Morishima, C. et al. Hepatology 43, 573–580 (2006).
Melhem, A. et al. J. Hepatol. 45, 60–71 (2006).
Radaeva, S. et al. Gastroenterology 130, 435–452 (2006).
Barry-Hamilton, V. et al. Nat. Med. 16, 1009–1017 (2010).
Russo, F.P. et al. Gastroenterology 130, 1807–1821 (2006).
Berres, M.L. et al. J. Clin. Invest. 120, 4129–4140 (2010).
Nelson, D.R. et al. Hepatology 38, 859–868 (2003).
Pockros, P.J. et al. Hepatology 45, 569–578 (2007).
Di Bisceglie, A.M. et al. N. Engl. J. Med. 359, 2429–2441 (2008).
McHutchison, J. et al. Gastroenterology 138, 1365–1373 (2010).
Rosenbloom, J., Castro, S.V. & Jimenez, S.A. Ann. Intern. Med. 152, 159–166 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mehal, W., Iredale, J. & Friedman, S. Scraping fibrosis: Expressway to the core of fibrosis. Nat Med 17, 552–553 (2011). https://doi.org/10.1038/nm0511-552
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0511-552
This article is cited by
-
Pterostilbene: a potential therapeutic agent for fibrotic diseases
Inflammopharmacology (2024)
-
The potential role of miRNAs and regulation of their expression in the development of mare endometrial fibrosis
Scientific Reports (2023)
-
Yttrium Oxide Nanoparticles Attenuate L-Arginine Induced Chronic Pancreatitis
Biological Trace Element Research (2023)
-
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction
Nature Communications (2022)
-
Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway
Journal of Biomedical Science (2021)